1 – 10 of 51
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Postnatal origin of the chromosomal gains in older patients with high hyperdiploid acute lymphoblastic leukemia
(
- Contribution to journal › Letter
- 2023
-
Mark
B-lineage acute lymphoblastic leukemia causes cell-autonomous defects in long-term hematopoietic stem cell function
(
- Contribution to journal › Article
-
Mark
Overexpression of the key metabolic protein CPT1A defines mantle cell lymphoma patients with poor response to standard high dose chemotherapy independent of MIPI and complement established high-risk factors
(
- Contribution to journal › Article
-
Mark
The IgG-degrading enzyme, Imlifidase, restores the therapeutic activity of FVIII in inhibitor-positive hemophilia A mice
(
- Contribution to journal › Article
-
Mark
Characterization of therapy-related acute myeloid leukemia : increasing incidence and prognostic implications
(
- Contribution to journal › Article
- 2022
-
Mark
Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders in 94,579 cases and 368,348 matched controls
(
- Contribution to journal › Letter
-
Mark
Sequence-specific 2'-O-methoxyethyl antisense oligonucleotides activate human platelets through glycoprotein VI, triggering formation of platelet-leukocyte aggregates
(
- Contribution to journal › Article
-
Mark
A risk score based on real-world data to predict early death in acute promyelocytic leukemia
(
- Contribution to journal › Article
-
Mark
Schlafen2 is a regulator of quiescence in adult murine hematopoietic stem cells
(
- Contribution to journal › Article
-
Mark
Interleukin 4 promotes phagocytosis of murine leukemia cells counteracted by CD47 upregulation
(
- Contribution to journal › Article